KUWAIT CITY, Dec 2: In a recent interview with Dr. Rajesh Rajan, we discussed the new treatment targets and goals for preventing cardiovascular disease. Dr. Rajan has been instrumental in overseeing various clinical research registries focused on heart failure. According to Dr. Rajan, the new treatment targets and goals are aimed at providing individuals with clear guidelines on how to prevent and manage cardiovascular disease. These targets focus on several factors, including smoking, diet, physical activity, body weight, blood pressure, cholesterol levels, and diabetes. When it comes to smoking, Dr. Rajan emphasizes the key goal of eliminating exposure to tobacco in any form. Quitting smoking can significantly reduce the risk of cardiovascular disease, and individuals must seek support if needed. A healthy diet plays a crucial role in preventing cardiovascular disease. Dr. Rajan recommends a diet low in saturated fat, with a focus on whole grain products, vegetables, fruits, and fish. These food choices provide essential nutrients and help maintain a healthy heart.

Monitor
Regular physical activity is another important aspect. Dr. Rajan suggests aiming for 3.5-7 hours of moderately vigorous physical activity per week or 30-60 minutes most days. Engaging in regular exercise strengthens the heart and improves overall cardiovascular health. Maintaining a healthy body weight is also emphasized. The recommended body mass index (BMI) range is between 20-25 kg/m², with a waist circumference below 94 cm for men and 80 cm for women. Excess weight puts added strain on the heart, increasing the risk of heart-related conditions. Controlling blood pressure is crucial in preventing cardiovascular disease.

he target for blood pressure is below 140/90 mmHg. High blood pressure can damage blood vessels and increase the risk of heart disease and stroke. It is important to monitor and manage blood pressure effectively. Lowering LDL-C (low-density lipoprotein cholesterol) levels is a focus in preventing cardiovascular disease. The treatment targets for LDL-C vary based on the individual’s risk level. For individuals at very high risk, the goal is to achieve at least a 50% reduction in LDL-C from baseline, with an LDL-C goal of less than 1.4 mmol/L or 55 mg/dL. For high-risk individuals, the LDL-C goal is less than 1.8 mmol/L or 70 mg/dL, while for moderate-risk individuals, the goal is less than 2.6 mmol/L or 100 mg/dL. Apart from LDL-C, non-HDL-C (non-high-density lipoprotein cholesterol) and apolipoprotein levels are also important in managing cardiovascular disease risk. The secondary goals for non-HDL-C and apolipoprotein levels vary based on risk levels, with lower goals for higher-risk individuals. For individuals with diabetes, managing blood sugar levels is crucial. The target for glycated hemoglobin (HbA1c) in individuals with diabetes is below 7% or 53 mmol/mol. Effective management of blood sugar levels reduces the risk of cardiovascular disease.

Dr. Rajan emphasizes the importance of adopting healthy lifestyle choices. By following these treatment targets and goals, individuals can significantly reduce their risk of cardiovascular disease and improve their heart health. It is crucial to consult with healthcare professionals for personalized guidance based on individual circumstances and risk factors. The interview with Dr. Rajesh Rajan provided valuable insights into the new treatment targets and goals for preventing cardiovascular disease. These guidelines offer individuals a roadmap to a healthier heart and a reduced risk of cardiovascular complications.

Recognition
Dr. Rajan is a renowned Indian cardiologist at Al Amiri Hospital Kuwait and Chairman of the Indian Association of Clinical Cardiologists. Dr. Rajan also holds prestigious positions as the current President of the Association of MD Physicians and the managing editor of the esteemed Annals of Clinical Cardiology Journal by Wolters Kluwer. His contributions to the medical community are highly regarded, with notable achievements that include the invention of the RHF Risk Score calculator for heart failure patients and the development of Rajan’s and Kotevski’s modified Lipton’s classification. Beyond his groundbreaking research, Dr. Rajan has garnered recognition through various Fellowships from esteemed institutions such as the Royal College of London, Edinburgh, Ireland, and Glasgow. Moreover, he has been honored as a Fellow of the American College of Cardiology, the European Society of Cardiology, and the American Heart Association, further highlighting his expertise and commitment to cardiovascular health.

By Arab Times Staff